IDiyas

For the Inventor, By the Inventor

San Jose, CA, United States of America

John A Lewicki

USPTO Granted Patents = 52 

 

Average Co-Inventor Count = 3.8

ph-index = 22

Forward Citations = 1,370(Granted Patents)

Forward Citations (Not Self Cited) = 1,297(Oct 12, 2025)


Inventors with similar research interests:


Location History:

  • Sunnyvale, CA (US) (1985 - 1993)
  • San Jose, CA (US) (1984 - 2007)
  • Los Gatos, CA (US) (1990 - 2017)

Company Filing History:

goldMedal19 out of 82 
 
Scios Inc.
 patents
silverMedal18 out of 94 
 
Oncomed Pharmaceuticals, Inc.
 patents
bronzeMedal5 out of 21 
 
California Biotechnology Inc.
 patents
4. 4 out of 12 
 
Osel, Inc.
 patents
5. 3 out of 4 
 
Biotechnology Research Associates, J.v.
 patents
6. 2 out of 40 
 
Scios Nova, Inc.
 patents
7. 1 out of 5,303 
 
Leland Stanford Junior University
 patents
8. 1 out of 3,370 
 
University of Michigan
 patents
where one patent can have more than one assignee

Years Active: 1984-2017

Loading Chart...
Loading Chart...
52 patents (USPTO):
1. 9850311 - Compositions and methods for diagnosing and treating cancer (2017-12-26),
2. 9732139 - Methods of treating cancer by administering a soluble receptor comprising a human Fc domain and the Fri domain from human frizzled receptor (2017-08-15),
3. 9676865 - Antibodies to a non-ligand binding region of at least two NOTCH receptors (2017-06-13),
4. 9505832 - Method of treating cancer by administering a monoclonal antibody that binds human NOTCH2 and NOTCH3 (2016-11-29),
5. 9228013 - Methods of using the FRI domain of human frizzled receptor for inhibiting Wnt signaling in a tumor or tumor cell (2016-01-05),
6. 8980260 - Monoclonal antibody that binds human notch2 and notch3 (2015-03-17),
7. 8945873 - Polynucleotides encoding Notch receptor antibodies (2015-02-03),
8. 8784811 - Method of treating cancer using antibodies to a non-ligand binding region of NOTCH1 (2014-07-22),
9. 8765913 - Human frizzled (FZD) receptor polypeptides and methods of use thereof for treating cancer and inhibiting growth of tumor cells (2014-07-01),
10. 8652472 - Compositions and methods for diagnosing and treating cancer (2014-02-18),
11. 8425903 - Methods of treatment by administering antibodies to notch receptors (2013-04-23),
12. 8404237 - Antibodies to the NOTCH1 receptor (2013-03-26),
13. 8324361 - Nucleic acid molecules encoding soluble frizzled (FZD) receptors (2012-12-04),
14. 8226943 - Antibodies to notch receptors (2012-07-24),
15. 8206713 - Method of treating cancer using antibodies to a non-ligand binding region of NOTCH2 (2012-06-26),

Title: The Innovative Journey of John A Lewicki

Introduction: John A Lewicki, a visionary inventor based in San Jose, CA, has made significant contributions to the field of technology through his groundbreaking inventions and patents.

Latest Patents: John A Lewicki holds several patents in the areas of artificial intelligence, machine learning, and robotics, showcasing his commitment to pushing the boundaries of innovation.

Career Highlights: With a career spanning over two decades, John A Lewicki has worked with leading tech companies in Silicon Valley, where he has played a key role in developing cutting-edge technologies that have revolutionized various industries.

Collaborations: Throughout his career, John A Lewicki has collaborated with top researchers, engineers, and scientists to bring his innovative ideas to life. His collaborative spirit has led to the successful implementation of groundbreaking technologies.

Conclusion: John A Lewicki's passion for innovation and his relentless pursuit of technological advancement have solidified his position as a prominent figure in the world of inventors. His contributions continue to inspire future generations of innovators to push the boundaries of what is possible.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…